Rearranged During Transfection Fusions in Non-Small Cell Lung Cancer
Round 1
Reviewer 1 Report
In my opinion this paper is well written and describes the full landscape of RET+ NSCLC.
I think that the different chapters about MK TKI, selective TKI and immunotherapie and chemotherapy are of good length and complete.
One item should be given in more detail: PFS and OS confident intervals are missing
Author Response
I have made the modifications you have suggested and added confidence intervals to the PFS and OS values.
Many thanks for comments and appreciate you taking the time to review this article.
Reviewer 2 Report
This comprehensive review covers the ongoing clinical trial for patients with RET rearrangement. These review is interesting and is worth for publication.
Author Response
Many thanks for comments and appreciate you taking the time to review this article.